Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
9.98
-0.28 (-2.73%)
May 13, 2025, 4:00 PM - Market closed
Tyra Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 100.72 | 91.97 | 58.01 | 251.21 | 302.18 | 15.22 | Upgrade
|
| Short-Term Investments | 218.22 | 249.48 | 145.46 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 318.94 | 341.44 | 203.47 | 251.21 | 302.18 | 15.22 | Upgrade
|
| Cash Growth | -16.61% | 67.81% | -19.00% | -16.87% | 1884.90% | 13996.30% | Upgrade
|
| Other Receivables | 1.8 | 2 | 0.7 | - | - | - | Upgrade
|
| Receivables | 1.8 | 2 | 0.7 | - | - | - | Upgrade
|
| Prepaid Expenses | 3.82 | 4.02 | 7.5 | 6.08 | 1.88 | 0.06 | Upgrade
|
| Total Current Assets | 324.57 | 347.46 | 211.67 | 257.29 | 304.06 | 15.28 | Upgrade
|
| Property, Plant & Equipment | 7.47 | 7.72 | 8.15 | 3.54 | 2.09 | 0.47 | Upgrade
|
| Other Long-Term Assets | 11.44 | 8.38 | 6.03 | 5.35 | 0.56 | 0.26 | Upgrade
|
| Total Assets | 343.48 | 363.56 | 225.86 | 266.18 | 306.7 | 16.01 | Upgrade
|
| Accounts Payable | 2.5 | 0.59 | 4.66 | 1.15 | 0.55 | 0.66 | Upgrade
|
| Accrued Expenses | 11.32 | 13.59 | 10.39 | 4.42 | 2.86 | 1.05 | Upgrade
|
| Current Portion of Leases | 0.43 | 0.41 | 0.28 | 0.14 | 0.2 | 0.14 | Upgrade
|
| Total Current Liabilities | 14.25 | 14.59 | 15.33 | 5.7 | 3.62 | 1.86 | Upgrade
|
| Long-Term Leases | 5.7 | 5.81 | 6.22 | 2.48 | 0.98 | - | Upgrade
|
| Other Long-Term Liabilities | - | 0 | 0.05 | 0.17 | 0.37 | 0.14 | Upgrade
|
| Total Liabilities | 19.94 | 20.41 | 21.6 | 8.35 | 4.96 | 2 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | - | Upgrade
|
| Additional Paid-In Capital | 602.3 | 593.69 | 368.71 | 353.52 | 342.1 | 0.44 | Upgrade
|
| Retained Earnings | -279.46 | -251.31 | -164.83 | -95.7 | -40.37 | -14.08 | Upgrade
|
| Comprehensive Income & Other | 0.69 | 0.77 | 0.38 | - | - | - | Upgrade
|
| Total Common Equity | 323.53 | 343.15 | 204.26 | 257.83 | 301.74 | -13.64 | Upgrade
|
| Shareholders' Equity | 323.53 | 343.15 | 204.26 | 257.83 | 301.74 | 14.01 | Upgrade
|
| Total Liabilities & Equity | 343.48 | 363.56 | 225.86 | 266.18 | 306.7 | 16.01 | Upgrade
|
| Total Debt | 6.12 | 6.22 | 6.5 | 2.62 | 1.18 | 0.14 | Upgrade
|
| Net Cash (Debt) | 312.82 | 335.22 | 196.97 | 248.59 | 301 | 15.08 | Upgrade
|
| Net Cash Growth | -16.80% | 70.19% | -20.76% | -17.41% | 1895.75% | - | Upgrade
|
| Net Cash Per Share | 5.30 | 5.86 | 4.61 | 5.94 | 21.84 | 9.78 | Upgrade
|
| Filing Date Shares Outstanding | 53.18 | 53.09 | 52.52 | 42.43 | 41.11 | 1.83 | Upgrade
|
| Total Common Shares Outstanding | 53.09 | 50.75 | 43.02 | 42.35 | 40.95 | 1.83 | Upgrade
|
| Working Capital | 310.32 | 332.87 | 196.34 | 251.59 | 300.44 | 13.42 | Upgrade
|
| Book Value Per Share | 6.09 | 6.76 | 4.75 | 6.09 | 7.37 | -7.45 | Upgrade
|
| Tangible Book Value | 323.53 | 343.15 | 204.26 | 257.83 | 301.74 | -13.64 | Upgrade
|
| Tangible Book Value Per Share | 6.09 | 6.76 | 4.75 | 6.09 | 7.37 | -7.45 | Upgrade
|
| Machinery | 2.45 | 2.46 | 2.03 | 1.38 | 1.06 | 0.34 | Upgrade
|
| Leasehold Improvements | 0.47 | 0.47 | 0.4 | 0.16 | 0.14 | - | Upgrade
|
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.